Ulf Hoppmann is founder and Managing Director at Xelium. He brings over 20 years experience of international leadership roles in the Life Science industry and consulting.

​

Prior to joining Xelium, Ulf was Director Corporate Finance Life Science at Ernst and Young, London where he worked with international clients on acquisitions, divestitures, restructurings, licensing, and business development opportunities in the Life Science sector.

​

Previously, Ulf spent many years in the industry. He was responsible for Corporate Strategy and M&A at Shenzen listed Lianhetech, Shanghai where he led the internationalization of the company in Southeast Asia and the acquisition of Fine Organics in the UK.

 

Previously, Ulf was Vice President Global Business Development at Heraeus where he developed the business unit strategies. He executed several strategic transactions and commercial collaborations across the respective business areas in pharma contract manufacturing, catalysis, precious metals, and fuel cells.

Prior to that Ulf led acquisitions, equity investments, licensing deals and divestments in Biotech, Animal Health and Consumer Healthcare at Boehringer Ingelheim - total deal volume above USD 2bn.

​

Ulf is an advisory board member at Ofichem and co-founder of Green Energy materials.

Ulf holds a degree in Technical Chemistry and Business from the Technical University Berlin, Germany and a Master of International Business from the Macquarie University, Sydney.